Literature DB >> 20954073

Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.

Sang Woo Kim1, Hae Jong Kim, Young Jin Chun, Mie Young Kim.   

Abstract

Ceramide induces cell cycle arrest and apoptotic cell death associated with increased levels of p27(kip1). The aim of this study was to examine the effects of ceramide on p27(kip1) protein levels as a measure of cell cycle arrest and apoptosis. Results showed that ceramide increased p27(kip1) protein levels through activation of protein phosphatase 2A (PP2A) in PC-3 prostate cancer cells. Treatment of cells with the PP2A inhibitor okadaic acid or with PP2A-Cα siRNA inhibited ceramide-induced enhanced p27(kip1) protein expression and Akt dephosphorylation, and prevented Skp2 downregulation. Overexpression of constitutively active Akt attenuated ceramide-induced Skp2 downregulation and p27(kip1) upregulation. In addition, ceramide stimulated binding of the PP2A catalytic subunit PP2A-Cαβ to Akt as assessed by immunoprecipitation experiments, indicating that PP2A is involved in the induction of p27(kip1) via inhibition of Akt pathway. Finally, whether PP2A can regulate p27(kip1) expression independently of Akt pathway was determined. Knockdown of PP2A-Cα with siRNA reduced p27(kip1) levels in the presence of Akt inhibitor. These data reveal that PP2A is a regulator of ceramide-induced p27(kip1) expression via Akt-dependent and Akt-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954073     DOI: 10.1080/15287394.2010.511553

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  19 in total

1.  Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis.

Authors:  Glady Hazitha Samuel; Stefania Lenna; Andreea M Bujor; Robert Lafyatis; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2012-06-26       Impact factor: 4.563

Review 2.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

Review 3.  Involvement of ceramide in cell death responses in the pulmonary circulation.

Authors:  Irina Petrache; Daniela N Petrusca; Russell P Bowler; Krzysztof Kamocki
Journal:  Proc Am Thorac Soc       Date:  2011-11

Review 4.  Advances in determining signaling mechanisms of ceramide and role in disease.

Authors:  Jeffrey L Stith; Fabiola N Velazquez; Lina M Obeid
Journal:  J Lipid Res       Date:  2019-03-07       Impact factor: 5.922

5.  Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.

Authors:  José C Crispín; Sokratis A Apostolidis; Melissa I Finnell; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 6.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

7.  RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.

Authors:  Shaikamjad Umesalma; Courtney A Kaemmer; Jordan L Kohlmeyer; Blake Letney; Angela M Schab; Jacqueline A Reilly; Ryan M Sheehy; Jussara Hagen; Nitija Tiwari; Fenghuang Zhan; Mariah R Leidinger; Thomas M O'Dorisio; Joseph Dillon; Ronald A Merrill; David K Meyerholz; Abbey L Perl; Bart J Brown; Terry A Braun; Aaron T Scott; Timothy Ginader; Agshin F Taghiyev; Gideon K Zamba; James R Howe; Stefan Strack; Andrew M Bellizzi; Goutham Narla; Benjamin W Darbro; Frederick W Quelle; Dawn E Quelle
Journal:  J Clin Invest       Date:  2019-03-04       Impact factor: 14.808

8.  Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.

Authors:  Arun Bhardwaj; Seema Singh; Sanjeev K Srivastava; Richard E Honkanen; Eddie Reed; Ajay P Singh
Journal:  Mol Cancer Ther       Date:  2011-03-10       Impact factor: 6.261

Review 9.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Authors:  Jaya Sangodkar; Caroline C Farrington; Kimberly McClinch; Matthew D Galsky; David B Kastrinsky; Goutham Narla
Journal:  FEBS J       Date:  2015-11-14       Impact factor: 5.542

10.  Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.

Authors:  Amy S Farrell; Brittany Allen-Petersen; Colin J Daniel; Xiaoyan Wang; Zhiping Wang; Sarah Rodriguez; Soren Impey; Jessica Oddo; Michael P Vitek; Charles Lopez; Dale J Christensen; Brett Sheppard; Rosalie C Sears
Journal:  Mol Cancer Res       Date:  2014-03-25       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.